- Home
- HSTM vs CBLL Comparison
HSTM vs CBLL Comparison
Compare HSTM & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HSTM | CBLL |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 935.3M |
| IPO Year | 1999 | 2024 |
Fundamental Metrics
Financial Performance| Metric | HSTM | CBLL |
|---|---|---|
| Price | $34.71 | $27.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $35.00 | $28.57 |
| AVG Volume (30 Days) | 158.7K | ★ 494.6K |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.42% | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $304,064,000.00 | $89,063,000.00 |
| Revenue This Year | $8.35 | $29.66 |
| Revenue Next Year | $4.59 | $27.36 |
| P/E Ratio | $78.35 | ★ N/A |
| Revenue Growth | 4.26 | ★ 36.09 |
| 52 Week Low | $19.50 | $10.85 |
| 52 Week High | $35.61 | $28.19 |
Technical Indicators
Market Signals| Indicator | HSTM | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 66.85 | 56.34 |
| Support Level | $27.77 | $22.96 |
| Resistance Level | $35.61 | $28.11 |
| Average True Range (ATR) | 0.92 | 1.43 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 69.17 | 68.07 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
About CBLL CeriBell Inc.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.